A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 2,997,453 shares of STRO stock, worth $8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,997,453
Previous 4,447,634 32.61%
Holding current value
$8 Million
Previous $13 Million 20.41%
% of portfolio
0.03%
Previous 0.04%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.88 - $5.01 $4.18 Million - $7.27 Million
-1,450,181 Reduced 32.61%
2,997,453 $10.4 Million
Q2 2024

Aug 14, 2024

BUY
$2.92 - $5.33 $12.2 Million - $22.3 Million
4,186,938 Added 1606.06%
4,447,634 $13 Million
Q1 2024

May 15, 2024

SELL
$3.27 - $5.65 $81,750 - $141,250
-25,000 Reduced 8.75%
260,696 $1.47 Million
Q4 2023

Feb 14, 2024

SELL
$2.07 - $4.54 $512,227 - $1.12 Million
-247,453 Reduced 46.41%
285,696 $1.23 Million
Q3 2023

Nov 14, 2023

BUY
$3.29 - $4.9 $1.07 Million - $1.59 Million
324,145 Added 155.09%
533,149 $1.85 Million
Q2 2023

Aug 14, 2023

BUY
$4.25 - $5.88 $888,267 - $1.23 Million
209,004 New
209,004 $971,000
Q1 2023

May 15, 2023

SELL
$4.48 - $8.45 $3.54 Million - $6.68 Million
-790,600 Closed
0 $0
Q4 2022

Feb 14, 2023

BUY
$5.41 - $8.08 $430,636 - $643,168
79,600 Added 11.2%
790,600 $6.39 Million
Q3 2022

Nov 14, 2022

BUY
$5.17 - $7.11 $3.68 Million - $5.06 Million
711,000 New
711,000 $3.95 Million
Q4 2021

Feb 14, 2022

SELL
$14.25 - $23.53 $5.34 Million - $8.82 Million
-375,000 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$16.88 - $22.38 $12.9 Million - $17 Million
-761,600 Reduced 67.01%
375,000 $7.08 Million
Q2 2021

Aug 16, 2021

BUY
$18.03 - $23.82 $3.22 Million - $4.25 Million
178,400 Added 18.62%
1,136,600 $21.1 Million
Q1 2021

May 17, 2021

SELL
$20.29 - $27.54 $9.15 Million - $12.4 Million
-451,114 Reduced 32.01%
958,200 $21.8 Million
Q4 2020

Feb 16, 2021

BUY
$10.16 - $23.98 $4.05 Million - $9.56 Million
398,819 Added 39.47%
1,409,314 $30.6 Million
Q3 2020

Nov 16, 2020

BUY
$7.44 - $13.15 $3.05 Million - $5.4 Million
410,495 Added 68.42%
1,010,495 $10.2 Million
Q2 2020

Aug 14, 2020

BUY
$7.24 - $11.05 $4.34 Million - $6.63 Million
600,000 New
600,000 $4.66 Million
Q3 2019

Nov 15, 2019

SELL
$7.91 - $11.76 $2.55 Million - $3.79 Million
-322,377 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$9.69 - $12.23 $3.12 Million - $3.94 Million
322,377 New
322,377 $3.67 Million

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $139M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.